Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Resources Required for Implementation of SARS-CoV-2 Screening in Massachusetts K-12 Public Schools in Winter/Spring 2021

Stephanie S. Lee, Michelle Weitz, Kristin Ardlie, Amy Bantham, Michele Fronk Schuckel, Katey Goehringer, Caitlin Hogue, Rosy Hosking, Kathleen Mortimer, Alham Saadat, Jill Seaman-Chandler, Benjamin P. Linas, Andrea Ciaranello
doi: https://doi.org/10.1101/2021.12.10.21267568
Stephanie S. Lee
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle Weitz
2Section of Infectious Diseases, Boston Medical Center, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin Ardlie
3Broad Institute of MIT & Harvard, Cambridge MA 02142
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy Bantham
4Move to Live More, LLC, Somerville, MA 02144
DrPH, MS, MPP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michele Fronk Schuckel
5Town of Weston Public Health, Weston MA 02493
MBA, BSN, RN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katey Goehringer
6Wellesley Education Foundation and Safer Teachers, Safer Students Collaborative, Wellesley, MA 02482
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caitlin Hogue
Ed.M.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosy Hosking
7Broad Institute of MIT & Harvard
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen Mortimer
ScD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alham Saadat
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jill Seaman-Chandler
8Public Schools of Brookline
MEd, BSN, RN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin P. Linas
9Boston University Schools of Medicine and Public Health and Section of Infectious Diseases, Boston Medical Center
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Ciaranello
10Division of Infectious Disease and Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aciaranello@partners.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Importance CDC guidance emphasizes the importance of in-person education for students in grades kindergarten to 12 (K-12) during the COVID-19 pandemic. CDC encourage weekly SARS-CoV-2 testing of asymptomatic, unvaccinated students and staff (“screening”) to reduce infection risk and provide data about in-school SARS-CoV-2 prevalence where community incidence is high. The financial costs of screening assays have been described, but the human resource requirements at the school and district level to implement a SARS-CoV-2 screening program are not well known.

Objective To quantify the resources required to implement a screening program in K-12 schools.

Design, Setting, and Participants A consortium of Massachusetts public K-12 schools was formed to implement and evaluate a range of SARS-CoV-2 screening approaches. Participating districts were surveyed weekly about their programs, including: type of assay used, individual vs. pooled screening, approaches to return of results and deconvolution (identification of positive individual specimens) of positive pools, number and type of personnel implementing the screening program, and hours spent on program implementation.

Main Outcomes and Measures Costs, resource utilization

Results In 21 participating districts, over 21 weeks from January to June 2021, the positivity rate was 0.0%-0.21% among students and 0.0%-0.13% among educators/staff, and 4 out of 21 (19%) districts had at least one classroom transition to remote learning at any point due to a positive case. The average weekly cost to implement a screening program, including assay and personnel costs, was $17.00 per person tested; this was $46.68 for individual screenings and $15.61 for pooled screenings. The total weekly costs by district ranged from $1,644-$93,486, and districts screened between 58 and 3,675 people per week. The reported number of personnel working per week ranged from 1-5 to >50, and the total number of hours worked by all personnel ranged from 5-10 to >50.

Conclusion and Relevance The human resources required to implement SARS-CoV-2 screening in Massachusetts public K-12 schools were substantial. Where screening is recommended for the 2021-22 school year due to high COVID-19 incidence (e.g., where vaccination uptake is low and/or more infectious variants predominate), understanding the human resources required to implement screening will assist districts policymakers in planning.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved as "not human subjects research" by the Mass General Brigham institutional review board.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • KA: kardlie{at}broadinstitute.org

  • AB: abantham{at}movetolivemore.com

  • MFS: schuckel.m{at}WestonMA.gov

  • KG: kateygoehringer{at}yahoo.com

  • CH: email hoguec{at}newton.k12.ma.us

  • RH: email crhosking{at}gmail.com

  • KMM: email: Mortimer.kathleen{at}gmail.com

  • AS: email alhams999{at}gmail.com

  • JSC: email jill_seaman-chandler{at}psbma.org

Data Availability

All data produced in the present work are contained in the manuscript

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted December 13, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Resources Required for Implementation of SARS-CoV-2 Screening in Massachusetts K-12 Public Schools in Winter/Spring 2021
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Resources Required for Implementation of SARS-CoV-2 Screening in Massachusetts K-12 Public Schools in Winter/Spring 2021
Stephanie S. Lee, Michelle Weitz, Kristin Ardlie, Amy Bantham, Michele Fronk Schuckel, Katey Goehringer, Caitlin Hogue, Rosy Hosking, Kathleen Mortimer, Alham Saadat, Jill Seaman-Chandler, Benjamin P. Linas, Andrea Ciaranello
medRxiv 2021.12.10.21267568; doi: https://doi.org/10.1101/2021.12.10.21267568
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Resources Required for Implementation of SARS-CoV-2 Screening in Massachusetts K-12 Public Schools in Winter/Spring 2021
Stephanie S. Lee, Michelle Weitz, Kristin Ardlie, Amy Bantham, Michele Fronk Schuckel, Katey Goehringer, Caitlin Hogue, Rosy Hosking, Kathleen Mortimer, Alham Saadat, Jill Seaman-Chandler, Benjamin P. Linas, Andrea Ciaranello
medRxiv 2021.12.10.21267568; doi: https://doi.org/10.1101/2021.12.10.21267568

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (553)
  • Anesthesia (135)
  • Cardiovascular Medicine (1761)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (660)
  • Epidemiology (10803)
  • Forensic Medicine (8)
  • Gastroenterology (593)
  • Genetic and Genomic Medicine (2954)
  • Geriatric Medicine (287)
  • Health Economics (534)
  • Health Informatics (1930)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (631)
  • Infectious Diseases (except HIV/AIDS) (12520)
  • Intensive Care and Critical Care Medicine (693)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2801)
  • Nursing (151)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1469)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (867)
  • Pharmacology and Therapeutics (366)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2641)
  • Public and Global Health (5375)
  • Radiology and Imaging (1015)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (726)
  • Rheumatology (330)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (150)
  • Urology (126)